Render Target: SSR
Render Timestamp: 2025-03-20T20:10:29.891Z
Commit: 779953b12a5930618aae6aca7c87fb286faeb1d7
XML generation date: 2025-03-07 13:14:10.250
Product last modified at: 2025-02-07T08:01:10.348Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Antibody Sampler Kit
PDP - Template ID: *******4a3ef3a

Lysine Acetyltransferase Antibody Sampler Kit #8686

    Product Information

    Product Description

    The Lysine Acetyltransferase Antibody Sampler Kit provides an economical means to examine several lysine acetyltrasferases, including: Acetyl-CBP, CBP, GCN5L2, and PCAF. The kit contains enough primary antibody to perform two western blots per primary.

    Background

    CREB-binding protein (CBP) and p300 are highly conserved and functionally related transcriptional co-activators that associate with transcriptional regulators and signaling molecules, integrating multiple signal transduction pathways with the transcriptional machinery (1,2). CBP/p300 also contain histone acetyltransferase (HAT) activity, allowing them to acetylate histones and other proteins (2). The role of acetylation of CBP/p300 is of particular interest (2,3). Acetylation of p300 at Lys1499 has been demonstrated to enhance its HAT activity and affect a wide variety of signaling events (4). p300/CBP-associated factor (PCAF), also known as lysine acetyl-transferase 2B (KAT2B) (5), and General Control of Amino Acid Synthesis Yeast Homolog Like 2 (GCN5L2) (6) are transcriptional adaptor proteins in addition to HATs. PCAF functions as the catalytic subunit of the PCAF transcriptional co-activator complex (5). GCN5L2 functions as the catalytic subunit of the STAGA and TFTC transcription coactivator complexes (6). PCAF and GCN5L2 acetylate histone H3 at Lys14 and histone H4 at Lys8, both of which contribute to gene activation by modulating chromatin structure and recruiting additional co-activator proteins that contain acetyl-lysine binding bromo-domains (7,8). PCAF also acetylates non-histone proteins including transcriptional activators (p53, E2F1, MyoD) and general transcription factors (TFIIEβ and TFIIF) (9-12). GCN5L2 also acetylates non-histone proteins such as transcription activators (TAT, c-Myb) (13,14), transcription co-activators (PGC1-α) (15), and nuclear receptors (Steroidogenic Factor 1) (16). Acetylation of these proteins regulates their nuclear localization, protein stability, DNA binding, and co-activator association (13-16).
    1. Goodman, R.H. and Smolik, S. (2000) Genes Dev 14, 1553-77.
    2. Chan, H.M. and La Thangue, N.B. (2001) J Cell Sci 114, 2363-73.
    3. Yuan, L.W. and Giordano, A. (2002) Oncogene 21, 2253-60.
    4. Thompson, P.R. et al. (2004) Nat Struct Mol Biol 11, 308-15.
    5. Nagy, Z. and Tora, L. (2007) Oncogene 26, 5341-57.
    6. Candau, R. et al. (1996) Mol Cell Biol 16, 593-602.
    7. Schiltz, R.L. et al. (1999) J Biol Chem 274, 1189-92.
    8. Grant, P.A. et al. (1999) J Biol Chem 274, 5895-900.
    9. Bannister, A.J. and Miska, E.A. (2000) Cell Mol Life Sci 57, 1184-92.
    10. Liu, L. et al. (1999) Mol Cell Biol 19, 1202-9.
    11. Sartorelli, V. et al. (1999) Mol Cell 4, 725-34.
    12. Imhof, A. et al. (1997) Curr Biol 7, 689-92.
    13. Kiernan, R.E. et al. (1999) EMBO J 18, 6106-18.
    14. Tomita, A. et al. (2000) Oncogene 19, 444-51.
    15. Lerin, C. et al. (2006) Cell Metab 3, 429-38.
    16. Jacob, A.L. et al. (2001) J Biol Chem 276, 37659-64.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    U.S. Patent No. 7,429,487, foreign equivalents, and child patents deriving therefrom.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.